Literature DB >> 16584132

The chinchilla microdialysis model for the study of antibiotic distribution to middle ear fluid.

Belinda W Y Cheung1, Wei Liu, Ping Ji, Linda L Cartier, Zhihong Li, Nael Mostafa, Ronald J Sawchuk.   

Abstract

In cases of slow or limited penetration of an antibiotic to the site of infection such as in acute otitis media (the middle ear), plasma levels of the agent may not reflect the concentrations that are relevant in determining clinical outcome. There is a need for a model that allows prediction of the time-course of unbound, pharmacologically active drug levels in middle ear fluid (MEF). This article introduces microdialysis as a sampling tool to measure unbound antibiotic concentrations in the MEF of the chinchilla, and briefly summarizes the results of studies of MEF penetration of a cephalosporin, a macrolide, and a ketolide antibiotic using this technique. The general concurrence of preliminary results of the chinchilla studies with clinical findings suggests that the chinchilla microdialysis model may be useful in predicting efficacy in patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16584132      PMCID: PMC2751422          DOI: 10.1208/aapsj080105

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  20 in total

Review 1.  Fundamental basis for rational therapeutics in acute otitis media.

Authors:  J L Blumer
Journal:  Pediatr Infect Dis J       Date:  1999-12       Impact factor: 2.129

2.  In vitro activity of the ketolide HMR 3647 (RU 6647) for Legionella spp., its pharmacokinetics in guinea pigs, and use of the drug to treat guinea pigs with Legionella pneumophila pneumonia.

Authors:  P H Edelstein; M A Edelstein
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

Review 3.  Otitis media: back to basics.

Authors:  H Faden; L Duffy; M Boeve
Journal:  Pediatr Infect Dis J       Date:  1998-12       Impact factor: 2.129

4.  Antibacterial activity of RU 64004 (HMR 3004), a novel ketolide derivative active against respiratory pathogens.

Authors:  C Agouridas; A Bonnefoy; J F Chantot
Journal:  Antimicrob Agents Chemother       Date:  1997-10       Impact factor: 5.191

Review 5.  Causative pathogens, antibiotic resistance and therapeutic considerations in acute otitis media.

Authors:  S L Block
Journal:  Pediatr Infect Dis J       Date:  1997-04       Impact factor: 2.129

6.  Microdialysis studies of the middle ear distribution kinetics of amoxicillin in the awake chinchilla.

Authors:  Y Huang; P Ji; A Inano; Z Yang; G S Giebink; R J Sawchuk
Journal:  J Pharm Sci       Date:  2001-12       Impact factor: 3.534

Review 7.  Otitis media: the chinchilla model.

Authors:  G S Giebink
Journal:  Microb Drug Resist       Date:  1999       Impact factor: 3.431

8.  Pharmacokinetics and pharmacodynamics of new and old antimicrobial agents for acute otitis media.

Authors:  J L Blumer
Journal:  Pediatr Infect Dis J       Date:  1998-11       Impact factor: 2.129

9.  Clinical implications of antibiotic resistance for management of acute otitis media.

Authors:  J O Klein
Journal:  Pediatr Infect Dis J       Date:  1998-11       Impact factor: 2.129

10.  Experimental acute otitis media due to nontypeable Haemophilus influenzae: comparison of high and low azithromycin doses with placebo.

Authors:  Franz E Babl; Stephen I Pelton; Zhong Li
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

View more
  2 in total

Review 1.  Utility of Microdialysis in Infectious Disease Drug Development and Dose Optimization.

Authors:  Amelia N Deitchman; M Tobias Heinrichs; Vipada Khaowroongrueng; Satyawan B Jadhav; Hartmut Derendorf
Journal:  AAPS J       Date:  2016-12-09       Impact factor: 4.009

2.  Comparison of Dexmedetomidine-Ketamine with Isoflurane for Anesthesia of Chinchillas (Chinchilla lanigera).

Authors:  Lana Fox; Lindsey Bc Snyder; Christoph Mans
Journal:  J Am Assoc Lab Anim Sci       Date:  2016       Impact factor: 1.232

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.